Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2

Vascul Pharmacol. 2024 Jun:155:107329. doi: 10.1016/j.vph.2024.107329.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Action Potentials* / drug effects
  • Estradiol / pharmacology
  • Estrogens / metabolism
  • Estrogens / pharmacology
  • Female
  • Humans
  • Induced Pluripotent Stem Cells* / drug effects
  • Induced Pluripotent Stem Cells* / metabolism
  • Long QT Syndrome* / metabolism
  • Long QT Syndrome* / physiopathology
  • Myocytes, Cardiac* / drug effects
  • Myocytes, Cardiac* / metabolism
  • Myocytes, Cardiac* / pathology
  • Phenotype

Substances

  • Estrogens
  • Estradiol

Supplementary concepts

  • Long Qt Syndrome 2